The president's attack carried particularly ominous implications for Frazier since Trump campaigned against pharmaceutical industry practices, and the White House is expected to soon release its long-promised executive order to rein in drug prices.
Frazier’s decision and his subsequent tongue-lashing on Twitter illustrate the tricky balancing act for America’s CEOs: Avoid Trump and run the risk of being his target — or get close to this White House at your peril.
More than two dozen CEOs and other leaders were invited to serve on Trump’s councils, a somewhat symbolic role that gives business executives a chance to bend the ear of the president and potentially win favorable treatment.
"Ken Frazier resigned because the President of the United States refused to condemn white supremacists," former Obama speechwriter Jon Favreau tweeted on Monday, with a link to a list of council members.
"The councils can provide a valuable tool for business leaders to raise issues … at the highest levels of the administration," said Michael Steel of Hamilton Place Strategies, which has advised clients on working with the White House.
- Merck chief Ken Frazier resigns from Trump councilBBC News
- Merck CEO resigns from White House council to 'take a stand against ...Los Angeles Times
- Merck's CEO Took a Stand. What About Other Executives?New York Times
- Trump Attacks Exec for Quitting Council Over CharlottesvilleU.S. News & World Report
- Here's What You Can Do After CharlottesvilleThe Nation.
- What Trump has done to lower the 'RIPOFF DRUG PRICES' he's decryingYahoo Finance
- Nucor CEO to stay on Trump council after Merck leader resignsCharlotte Observer
- Merck CEO resigns from Trump council over CharlottesvilleReuters
- Merck CEO Ken Frazier Quits Advisory Council After Trump's Charlottesville ...GOOD Magazine